Risk Audit · Cached SEC Snapshot
IOVA Risk Audit — Dilution, Cash Runway, and SEC Filings
IOVANCE BIOTHERAPEUTICS, INC.
TL;DR
- MODERATE / CAUTION — No fatal flags, but the structure is not pristine. Read the evidence.
- Doomsday Clock: 32.7mo of cash before the company exhausts its operating runway.
- Dilution Risk: 31 / 100 — heavy active dilution; shareholders likely diluted.
- Dilution Status: High Dilution Risk — Share count changed by +31.2%. No active dilution drivers detected in latest filing.
Doomsday Clock
32.7mo
Company runs out of cash in 32.7 months
Dilution Risk
31 / 100
High dilution — shareholders likely diluted
C
Stockteller Grade
Altman Z: -2.98 (Z)
Gravity Playbook · Mathematical Stress Test
AUTH
Dilution Authorization
The company is authorized to issue equity via an active S-3 shelf registration. Current mechanics indicate no active dilution, but an annual dilution capacity of 31.20% is authorized.
BURN
Cash Burn Rate
Current mechanics indicate the company's cash runway is mathematically depleted in approximately 32.72 months based on current burn rates.
COMPLIANCE
Nasdaq Compliance
Nasdaq requires a $1.00 minimum bid. Historical precedent for companies with this profile involves structural actions such as reverse splits to maintain listing compliance.
Mechanical analysis only. Not financial advice. Statements describe mathematical conditions and historical precedent, not predictions or recommendations for this security.
Educational analysis only. Not financial advice. The Risk Audit is a quantitative framework derived from publicly available SEC filings and may contain inaccuracies. AI systems are fallible. Always verify against the source filings on
SEC EDGAR
and consult a licensed advisor before making investment decisions.